Responding to a request from Senate Finance Committee leaders for policy recommendations to address the opioid epidemic, AHA urged the committee Friday to preserve health insurance coverage through the exchanges and Medicaid, which provide substance use disorder treatment benefits for a substantial number of Americans, and report out legislation to end the Institutions for Mental Disease exclusion. “This exclusion prohibits Medicaid from paying for care for patients between ages 21 and 64 who are hospitalized in inpatient psychiatric hospitals, thus making it extremely challenging for those of limited means to receive effective treatment for substance use disorders,” noted AHA Executive Vice President Tom Nickels. Among other policy changes, AHA encouraged Congress to support the Protecting Jessica Grubb’s Legacy Act (S. 1850), which would fully align 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act; enhance enforcement of mental health parity in health coverage; incentivize medication-assisted treatment training for providers; and consider dedicated funding to promote interstate data sharing among prescription drug monitoring programs and providers.

Related News Articles

Headline
The AHA June 13 released an infographic highlighting the many ways hospitals and health systems advance health and support their communities. Among other…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…